Hyperammonaemia

Gene: DBT

Green List (high evidence)

DBT (dihydrolipoamide branched chain transacylase E2)
EnsemblGeneIds (GRCh38): ENSG00000137992
EnsemblGeneIds (GRCh37): ENSG00000137992
OMIM: 248610, ClinGen, DECIPHER
DBT is in 12 panels

1 review

Teresa Zhao (Victorian Clinical Genetics Services)

Green List (high evidence)

well reported gene causing Maple syrup urine disease, type II (MIM#248600)
Created: 24 Jul 2020, 6:19 p.m. | Last Modified: 24 Jul 2020, 6:19 p.m.
Panel Version: 0.3507

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Maple syrup urine disease, type II (MIM#248600)

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • Expert Review Green
  • Genomics England PanelApp
Phenotypes
  • Maple syrup urine disease, type II 248600
Tags
treatable
OMIM
248610
ClinGen
DBT
DECIPHER
DBT
Clinvar variants
Variants in DBT
Penetrance
None
Panels with this gene

History Filter Activity

26 Sep 2022, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: dbt has been classified as Green List (High Evidence).

26 Sep 2022, Gel status: 3

Added Tag

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Tag treatable tag was added to gene: DBT.

29 Jan 2021, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: DBT was added gene: DBT was added to Hyperammonaemia. Sources: Genomics England PanelApp,Expert Review Green Mode of inheritance for gene: DBT was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: DBT were set to Maple syrup urine disease, type II 248600